Menu

Recent Interviews

Humphrey Hale, CEO, Managing Geologist, Carnavale Resources Ltd.

Humphrey Hale
CEO, Managing Geologist | Carnavale Resources Ltd.
Level 2, Suite 9 389 Oxford Street, WA 6016 Mount Hawthorn (AUS)

info@carnavaleresources.com

Interview Carnavale Resources: Good cards for long-term success


Bill Guy, Chairman, Theta Gold Mines Limited

Bill Guy
Chairman | Theta Gold Mines Limited
Level 35 (ServCorp), Intl Tower One 100 Barangaroo Ave, 2000 NSW Australia (AUS)

info@thetagoldmines.com

+61 2 8046 7584

Interview Theta Gold Mines: This team has already brought 20 mines into production


David Mason, Managing Director, CEO, NewPeak Metals Ltd.

David Mason
Managing Director, CEO | NewPeak Metals Ltd.
Level 27, 111 Eagle Street, QLD 4000 Brisbane (AU)

info@newpeak.com.au

+61 7 3303 0650

Interview New Peak Metals: Many chances for great success


11. November 2020 | 13:22 CET

NEL ASA, dynaCERT, Bayer: Reallocation offers excellent opportunities

  • Investments
Photo credits: pixabay.com

After yesterday's triumphant announcement regarding a possible vaccine against the Corona Virus, a rift in the stock market seems to be in full swing. Highly praised tech shares and the profiteers of the Corona Crisis are falling through the bank. In contrast, there is a rebirth of the old economy and cyclical stocks. Oil stocks are also picking up again. The hope for an economic revival is becoming more tangible and creates excellent opportunities for the Fallen Angels.

time to read: 3 minutes by Stefan Feulner
ISIN: CA26780A1084 , NO0010081235 , DE000BAY0017


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Climate change mainstream again

The Corona Pandemic has been the number one topic of conversation in recent months; however, climate change will likely find its way back into mainstream media once life normalizes again. "Fridays For Future" and Greta, will once again call for the world to be saved, and politicians who are currently acting as corona saviors, such as Bavarian Prime Minister Markus Söder, will once again put the ban of the internal combustion engine on the agenda.

Green technology and hydrogen

This is precisely where dynaCERT Inc., which was founded in 2001, comes in. The basic idea of the Canadians is to reduce the pollutant emissions of diesel-powered vehicles. For this purpose, retrofitting units for diesel engines have been developed which use hydrogen as a catalyst. This reduces both fuel consumption and CO2 emissions in peak times, by up to 20%.

Trucks (still) in the foreground

The target group of dynaCERT is, however, not yet the millions of passenger cars, but primarily fleet operators. The goal is to retrofit the millions of trucks still running on diesel. With the specially developed software "HydraLitica" (TM) it is possible to monitor the fuel savings. Building on this platform, the Company recently announced additional services such as fleet management, route planning, driver safety and load management. The Company's technology is currently being tested in more than 400 vehicles.

Analysts extremely bullish

The analyst firm GBC Research seems to be highly impressed. The experts set the dynaCERT share at a clear buy. The target price was set at no less than CAD 2.20 by the end of 2021. As of yesterday, the share price was at CAD 0.50, offering considerable upside potential. The Canadians have definitely taken the pulse of the times.

Insiders started buying

At the moment, positive and negative reports are coming from the pharmaceutical and agricultural giant, Bayer AG. After the share price reached a 5-year low of EUR 40.36 last week, the first insiders started to buy. Bayer CEO, Werner Baumann, ordered shares worth around EUR 2.45 million. Also, Chief Financial Officer Wolfgang Nickl and Heiko Schipper, responsible for the health products business, increased their portfolio with shares for EUR 154,000 and EUR 309,000 respectively.

Hope for approval

The application for approval of Bayer's renal drug, Finerenon, in the USA and the European Union is also positive. The applications were submitted simultaneously to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Finerenon is considered a new treatment option for slowing the progression of chronic kidney disease. According to industry experts, the drug has a potential of up to EUR 1.5 billion per year.

Sword of Damocles Monsanto

However, the glyphosate controversy continues to dominate all news. The US judge in charge is putting pressure on the Leverkusen-based Company. He wants to resume negotiations in some unresolved cases. Bayer wanted to take the litigation off the table last summer with a large-scale settlement of USD 9.6 billion. However, this settlement was rejected by the court. According to the Bayer leadership, the settlement package increased to around EUR 11.6 billion as of the beginning of November. The uncertainty remains. In the last two weeks, the price of the Bayer stock has recovered by almost 20% and, from a chartist's point of view, is on the verge of the downward trend that began in June and currently stands at just under EUR 49. In the event of a successful breakthrough, the gap to EUR 52.60 should be closed quickly.

NEL ASA keeps hoarding orders

Almost every week the Norwegian hydrogen specialist can shine with new orders. This time the subsidiary, Nel Hydrogen US, received orders for PEM electrolyzer cell stacks worth more than USD 5.4 million from none other than Raytheon Technologies. Nel Hydrogen US is the exclusive supplier of electrolyzer stacks to the United States Navy. The stacks produce vital oxygen for the crews on several classes of nuclear-powered submarines.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

23. June 2021 | 12:21 CET | by Armin Schulz

Commerzbank, wallstreet:online, Volkswagen - What is the German stock market doing?

  • Investments

Last Friday, there was the so-called witches' Sabbath, and the DAX fell by over 300 points, but by Monday, the buyers returned. All signs point to economic recovery, also in the USA. The FED has announced that it does not intend to raise interest rates before 2023, despite inflation significantly higher than Germany. The European Central Bank has not yet announced anything about raising interest rates. They are trying to keep the economy going, and Mr. Draghi had tried to fan inflation for a long time but failed at the time. The ECB would undoubtedly like to see inflation of 2-3% over a more extended period, and that makes investing in stocks or other tangible assets still attractive.

Read

22. June 2021 | 15:02 CET | by Nico Popp

JinkoSolar, Defense Metals, Gazprom: Values for the yield kick

  • Investments

The fight against climate change is an ideological issue in many places. That is why there are bitter opponents of the measures. But clean energy should be in everyone's interest - at least if it is profitable to produce. Many people rightly have reservations about pushing technology onto the market solely based on subsidies. History has shown that this creates the wrong incentives and even restricts the development of technology that could become established in the long term.

Read

22. June 2021 | 14:07 CET | by Stefan Feulner

Steinhoff, Barsele Minerals, Bayer - This is explosive for the stock markets

  • Investments

Will the central banks change their direction, or will "the policy of cheap money" remain in place with unlimited bond purchases and zero interest rates to benefit growth? Last week, the markets were already caught on the wrong foot after the FED forecast two interest rate hikes for 2023. Then, the President of the St. Louis Fed, James Bullard, added even more salt to investors' wounds. He sees an accelerated tightening of monetary policy as a normal reaction to economic growth and rampant inflation in the wake of the economy's return from the Corona shock.

Read